These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24722247)

  • 1. Retraction. Activation of aldose reductase by interaction with tubulin and involvement of this mechanism in diabetic cataract formation. Diabetes. 10 April 2014 [Epub ahead of print]. DOI: 10.2337/db13-1265.
    Diabetes; 2014 Aug; 63(8):2896. PubMed ID: 24722247
    [No Abstract]   [Full Text] [Related]  

  • 2. Update of retraction--Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy. Diabetes. 19 November 2012 [Epub ahead of print]. DOI: 10.2337/db12-0317.
    Diabetes; 2014 May; 63(5):1817. PubMed ID: 24757205
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction of: DNA Cell Biol, 2017; 36 [Epub ahead of print]; DOI: 10.1089/dna.2017.3798.
    DNA Cell Biol; 2017 Oct; 36(10):878. PubMed ID: 28937284
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement of Retraction. Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy. Diabetes. 19 November 2012 [Epub ahead of print].
    Rincon N; Xu K; Li J; Martinez JA; Singh GS; Han D; Lalli P; Ayer A; Tse K; Rong L; Schmidt AM; Toth CC
    Diabetes; 2013 Jan; 62(1):309. PubMed ID: 22936180
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction of: Bansal and Arora. J Endourol. Epub ahead of print; DOI: 10.1089/end.2016.0696.
    J Endourol; 2017 Mar; 31(3):326. PubMed ID: 28263696
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction for Christensen CC, Antoszewski S, Maus E, et al. Establishing Reference Values for Infant Head Shape Using a Modified Version of Plagiocephalometry. Phys Ther. Epub ahead of print May 12, 2016. doi: 10.2522/ptj.20150366.
    Phys Ther; 2016 Aug; 96(8):1299. PubMed ID: 27174258
    [No Abstract]   [Full Text] [Related]  

  • 10. High glucose levels induce inhibition of Na,K-ATPase via stimulation of aldose reductase, formation of microtubules and formation of an acetylated tubulin/Na,K-ATPase complex.
    Rivelli JF; Amaiden MR; Monesterolo NE; Previtali G; Santander VS; Fernandez A; Arce CA; Casale CH
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1203-13. PubMed ID: 22565168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction of: Bone Mesenchymal Stem Cell-Conditioned Medium Regulates the Differentiation of Neural Stem Cells Via Notch Pathway Activation, by Li H-M, Tong Y, Xia X, Huang J, Song P-W, Zhang R-J, Shen C-L. Cell Reprogram. [Epub ahead of print; Dec 27, 2018] DOI: 10.1089/cell.2018.0042.
    Cell Reprogram; 2019 Feb; 21(1):61. PubMed ID: 30735077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV; Takahashi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of aldose reductase inhibitors to prevent diabetic complications.
    Zenon GJ; Abobo CV; Carter BL; Ball DW
    Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    J Comput Biol; 2020 Apr; 27(4):673. PubMed ID: 32196383
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction of: Redox-Sensing Iron-Sulfur Cluster Regulators, by Crack JC, Le Brun NE. Antioxid Redox Signal [Epub ahead of print]; DOI: 10.1089/ars.2017.7369, 2017.
    Antioxid Redox Signal; 2018 Feb; ():. PubMed ID: 29431469
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction of: Long Noncoding RNA SOX2OT Accelerates the Carcinogenesis of Wilms' Tumor Through ceRNA Through miR-363/FOXP4 Axis, by Ma L, Sun X, Kuai W, Hu J, Yuan Y, Feng W, and Lu X. DNA Cell Biol [Epub ahead of print]; DOI: 10.1089/dna.2018.4420, 2018.
    DNA Cell Biol; 2019 Jan; 38(1):114. PubMed ID: 30576227
    [No Abstract]   [Full Text] [Related]  

  • 20. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.